Risk of cancer onset in sub-Saharan Africans affected with chronic gastrointestinal parasitic diseases

International Journal of Immunopathology and Pharmacology

Volumn 18, Issue 3, 2005, Pages 503-511

  Waku, M ^a   Napolitano, Luca ^b,e   Clementini, E ^b   Staniscia, T ^b   Spagnolli, C ^c   Andama, A ^d   Kasiriye, P ^d   Innocenti, P ^b  

^a Arua Referral Hospital   (Uganda)

^b Chieti University Italy   (Italy)

^c Luisa Guidotti Hospital   (Zimbabwe)

^d MULAGO HOSPITAL   (Uganda)

^e UNIVERSITY OF CHIETI   (Italy)

Author keywords

Amoebiasis; Aspecific enterocolitis; Cancer of the digestive system; Chronic inflammation of the GI tract; Intestinal TBC; Oesophageal candidiasis; Schistosomiasis

Indexed keywords

ABDOMINAL PAIN; ADULT; AFRICA; AFRICAN AMERICAN; AMEBIASIS; AMOEBA; ARTICLE; CANCER EPIDEMIOLOGY; CANCER RISK; CANDIDIASIS; CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; DIARRHEA; DIGESTIVE SYSTEM CANCER; ENTEROCOLITIS; ESOPHAGUS CANCER; ESOPHAGUS DISEASE; FECES INCONTINENCE; FEMALE; GASTROINTESTINAL INFECTION; GASTROINTESTINAL MUCOSA; HEMATEMESIS; HUMAN; INFLAMMATORY DISEASE; INTESTINE TUBERCULOSIS; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MELENA; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RECTUM DISEASE; SCHISTOSOMA; SCHISTOSOMIASIS; SMALL INTESTINE CANCER; STOMACH CANCER; UGANDA; VOMITING; ZIMBABWE;

EID: 27444445717     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200501800310     Document Type: Article

References (27)

1. Nash T.E., A.W. Cheever, E.A. Ottesen and J.A. Cook. 1982. Schistosome infections in humans: perspectives and recent findings. NIH conference. Ann. Intern. Med. 97:740.
2. Kopterides P. 2003. Amebiasis. N. Engl J. Med. 17:307.
3. Misra S.P., V. Misra, M. Dwivedi, P.A. Singh and R. Barthwal. 2004. Factors influencing colonic involvement in patients with amebic liver abscess. Gastrointest. Endosc. 59:512.
4. Ross A.G., L. Yuesheng, A.C. Sleigh, G.M. Williams, G.F. Hartel, S.J. Forsyth, L. Yi and D.P. McManus. 1998. Measuring exposure to S. japonicum in China. I. Activity diaries to assess water contact and comparison to other measures. Acta Trop. 71:213.
5. Karlinger K., T. Gyorke, E. Mako, A. Mester and Z. Tarjan. 2000. The epidemiology and the pathogenesis of inflammatory bowel disease. Eur. J. Radial. 35:154.
6. Niv Y., G. Abuksis and G.M. Fraser. 2000. Epidemiology of ulcerative colitis in Israel: a survey of Israeli kibbutz settlements. Am. J. Gastroenterol. 95:693.
7. Matsumoto T. and M. Fujishima. 1999. Epidemiologic aspects of ulcerative colitis in Japan - comparison with other countries. Nippon Rinsho. 57:2443.
8. Tragnone A., G. Corrao, F. Miglio, R. Caprilli and G.A. Lanfranchi. 1996. Incidence of inflammatory bowel disease in Italy: a nationwide population-based study. Gruppo Italiano per lo Studio del Colon e del Retto (GISC). Int. J. Epidemiol. 25:1044.
9. Itzkowitz S.H. 1997 Inflammatory bowel disease and cancer. Gastroenterol. Clin. North Am. 26:129.
10. Mpofu C., A. Watson and J. Rhodes. 2004. Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease. Cochrane Database Syst. Rev. CD000279
11. Coussens L.M. and Z. Werb 2002. Inflammation and cancer. Nature. 420:860.
12. Shacter E and S.A. Weitzman 2002. Chronic inflammation and cancer. Oncology (Huntingt). 16:217.
13. Rhodes J.M. and B.J. Campbell. 2002. Inflammation and colorectal cancer: IBD-associated and sporadic cancer compared. Trends Mol. Med. 8:10.
14. Frydas S., M. Hatzistilianou, E. Karagouni, B. Madhappan, N. D'Orazio, G. Riccioni, F. Conti, G. Caratelli and D. Kempuraj. 2003. Chemokines and parasites. Int. J. Immunopathol. Pharmacol. 16:221.
15. Frydas S., B. Madhappan and D. Kempuraj. 2002. Some aspects of Parasitology and Immunology in general Medicine. Int. J. Immunopathol. Pharmacol. 15:165.
16. Van der Woude C.J., J.H. Kleibeuker, P.L. Jansen and H. Moshage. 2004. Chronic inflammation, apoptosis and (pre-)malignant lesions in the gastrointestinal tract. Apoptosis 9:123.
17. Hudson J.D., M.A. Shoaibi, R. Maestro, A. Carnero, G.J. Hannon and D.H. Beach. 1999. A proinflammatory cytokine inhibits p53 tumor suppressor activity. J. Exp. Med. 15:1375.
18. Zhang R., S. Takahashi, S. Orita, A. Yoshida, H. Maruyama, T. Shirai and N. Ohta. 1998. p53 gene mutations in rectal cancer associated with schistosomiasis japonica in Chinese patients. Cancer Lett. 25:215.
19. Campbell B.J., L.G. Yu and J.M. Rhodes. 2001. Altered glycosylation in inflammatory bowel disease: a possible role in cancer development. Glycoconj J. 18:851.
20. Cox D.G., C. Pontes, E. Uino, M. Avarro, A. Osorio, F. Canzian and V. Moreno. 2004. Polymorphisms in prostaglandin synthase 2/cyclooxygenase 2 (PTGS2/COX2) and risk of colorectal cancer. Br. J. Cancer 19:339.
21. Conti P. 2003. COX-2 and COX-2 enzyme inhibition. Int. J. Immunopathol. Pharmacol. 16(S):I.
22. Sun B., J. Nishihira, S. Muzuki, N. Fukushima, T. Ishibashi, M. Kondo, Y. Sato and S. Todo. 2003. Induction of macrophage migration inhibitory factor by lysophosphatidic acid: relevance to tumor growth and angiogenesis. Int. J. Mol. Med. 12:633.
23. Balkwill F. and A. Mantovani. 2001. Inflammation and cancer: back to Virchow? Lancet 17:539.
24. Chen M.C., P.Y. Chang, C.Y. Chuang, Y.J. Chen, F.P. Wang and Y.C. Tang. 1981. Colorectal cancer and schistosomiasis. Lancet 2:971.
25. Jatzko G., R. Kleinert and H. Denk. 1997. Intestinal schistosomiasis, a facultative precancerous condition? Review of the literature with reference to Schistosoma japonicum associated rectum carcinoma. Chirurg. 68:727.
26. Ishii A., H. Matsuoka., T. Aji, N. Ohta, S. Arimoto, Y. Wataya and H. Hayatsu. 1994. Parasite infection and cancer: with special emphasis on Schistosoma japonicum infections (Trematoda). A review. Mutat. Res. 1:273.
27. Choi P.M. and M.P. Zelig. 1994. Similarity of colorectal cancer in Crohn's disease and ulcerative colitis: implications for carcinogenesis and prevention. Gut 35:950.